Lonika Lodha

Dr. Lonika Lodha

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in The Lancet Regional Health - Southeast Asia
Verified
Journal Article
Open access
LLLonika Lodha
Lonika Lodha
AAAshwini Manoor Ananda
Ashwini Manoor Ananda
RMReeta Mani
Reeta Mani
Rabies is a fatal zoonotic encephalitis that is responsible for approximately 59,000 deaths worldwide every year. A significant portion of these deaths, about one-third, occur in India alone. In order to meet the World Health Organization's objective of eliminating dog-mediated rabies by 2030, India has made considerable progress in this regard. However, implementing the current strategies of canine immunization, sterilization, and providing post-exposure prophylaxis to exposed individuals is challenging in a large and diverse country like India. This article aims to highlight the limitations of relying solely on post-exposure prophylaxis for the prevention of human rabies. Moreover, it presents the necessity and rationale for including pre-exposure immunization in India's national immunization schedule.

20 October 2022 in Journal of Laboratory Physicians
Verified
Journal Article
Open access
PDF file
LLLonika Lodha
Lonika Lodha
SMShivkumar Rashmi Mudliar
Shivkumar Rashmi Mudliar
JSJitendra Singh
Jitendra Singh
AMAnand Kumar Maurya
Anand Kumar Maurya
AKAlkesh Kumar Khurana
Alkesh Kumar Khurana
Sarman SinghSarman Singh
Sarman Singh
Objective The primary objective of this study was to assess the diagnostic performance of multiplex polymerase chain reaction (mPCR) for the detection of Mycobacterium tuberculosis complex (MTBC) in presumptive pulmonary TB patients, in the setting of a tertiary level teaching hospital in central India, in comparison to liquid culture using BACTEC mycobacteria growth indicator tubes (MGIT) 960 TB system as the gold standard. The secondary objective was to assess the performance of mPCR for Ziehl Neelsen smear negative samples and ascertain the utility of this assay in smear negative samples.Materials and Methods Sputum or bronchoalveolar lavage samples were collected from patients who were adults, aged 18 years or older, presenting with presumptive pulmonary TB, and subjected to three microbiological investigations, that is, Ziehl Neelsen staining, mycobacterial culture using mycobacterial growth indicator tubes in the BD BACTEC MGIT 960 instrument, and the mPCR.Statistical Analysis For statistical analysis, 2 × 2 contingency tables were prepared and analyzed separately for all samples and for smear-negative samples using GraphPad and MedCalc tools. Sensitivity, specificity, positive predictive value, and negative predictive value (NPV) of mPCR were calculated by taking MGIT culture as the reference standard.Results For all samples (n = 114), sensitivity of mPCR for the detection of (MTBC) was 93.48% (95% confidence interval [CI]: 82.10–98.63%), specificity was 95.59% (95% CI: 87.64–99.08%), positive predictive value (PPV) was 93.48% (95% CI: 82.54–97.75%), and NPV was 95.59% (95% CI: 87.87–98.48%). For smear negative samples (n = 80), sensitivity was 80.00% (95% CI: 51.91–95.67%), specificity was 98.46% (95% CI: 91.72–99.96%), PPV was 92.31% (95% CI: 62.80–98.84%), and NPV was 95.52% (95% CI: 88.57–98.33%).Conclusion In this study, we were able to demonstrate the good performance characteristics of the mPCR for the detection of MTBC from clinical samples of patients with presumptive pulmonary tuberculosis, with MGIT liquid culture as the reference standard. It may be concluded that mPCR can be considered equivalent to MGIT culture in terms of clinical decision making and yield of positivity, owing to the good sensitivity and specificity for the detection of MTBC.

14 September 2024 in The Lancet Regional Health - Southeast Asia
Verified
Journal Article
Open access
SUShruthi Uppoor
Shruthi Uppoor
TDTina Damodar
Tina Damodar
LLLonika Lodha
Lonika Lodha
MNMadhusudhan Huluvadi Nagarajaiah
Madhusudhan Huluvadi Nagarajaiah
RMReeta Mani
Reeta Mani

28 October 2025 in Infectious Diseases Now
Verified
Journal Article
Open access
LLLonika Lodha
Lonika Lodha
ASAkila Swaminathan
Akila Swaminathan
Abby JohnAbby John
Abby John
SKShalini Kunhikannan
Shalini Kunhikannan
BSBrindha Sundar
Brindha Sundar
APAmrita Pattanaik
Amrita Pattanaik
Chandipura virus (CHPV) is an emerging zoonotic pathogen of significant public health concern, particularly in the Indian subcontinent. The virus was first identified in 1965 during a dengue-like febrile outbreak in the village of Chandipur, Maharashtra, India. CHPV is a bullet- shaped enveloped rhabdovirus with a single-stranded, negative-sense RNA genome. CHPV infections are characterised by fatal acute encephalitis, specifically in the paediatric population under the age of 15, with a case fatality rate (CFR) of 57%-70% observed during outbreaks. CHPV transmission is believed to occur via sandflies (Phlebotomus spp.), with additional roles for other arthropod vectors not yet fully ruled out. CHPV infection in humans is characterized by a sudden onset of fever, vomiting, and altered sensorium, progressing swiftly to coma and death in severe cases. Various diagnostic approaches, including serological assays, molecular techniques, animal inoculation, and virus isolation, have been employed for CHPV detection. The lack of specific antiviral treatment or a licensed vaccine compounds the threat posed by CHPV, particularly in resource-limited settings. In the absence of a licenced vaccine, prevention of CHPV infection relies on reducing vector-borne transmission of the virus. This review comprehensively investigates several key questions related to the CHPV, including its epidemiology, transmission mechanisms, clinical presentations, diagnostic techniques, and potential treatments.

20 September 2023 in Journal of Medical Virology
Verified
Journal Article
Closed access
LLLonika Lodha
Lonika Lodha
AAAshwini M. Ananda
Ashwini M. Ananda
ARArya Ramachandran
Arya Ramachandran
SMSathya Priya Manuel
Sathya Priya Manuel
SSSujatha Valagere Sannaiah
Sujatha Valagere Sannaiah
RMReeta Mani
Reeta Mani

29 December 2025 in Journal of Medical Virology
Verified
Journal Article
Closed access
SGShipra Gupta
Shipra Gupta
VRVijayalakshmi Reddy
Vijayalakshmi Reddy
LLLonika Lodha
Lonika Lodha
MAM. A. Ashwini
M. A. Ashwini